Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

SHANGHAI - Swiss pharmaceutical giant Roche has announced plans to invest 2.04 billion yuan ($283 million) in building a new ...

Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The ...

The new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.

Roche plans to invest over $700 million in setting up a new plant in North Carolina and up to $550 million in expanding its Indianapolis diagnostics hub.

Under the agreement, AstraZeneca will establish a global strategic R&D center in Beijing ... Also in March, US-based pharmaceutical company Eli Lilly launched Lilly Gateway Labs in Beijing ...

Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 million plant in the Wake County town. It's the latest drugmaker to target the ...

Eli Lilly seems to have responded to the threat ... and reduced investment in R&D. Lilly's announcement comes just a few days after Lilly's chief executive, David Ricks, and other pharma leaders ...

Merck (NYSE:MRK) on Thursday announced plans to invest $895M to expand a manufacturing facility in Kansas, becoming the ...

Since 2020, Eli Lilly & Co. has committed at least $16 billion ... In April, the company announced plans to invest $50 billion in new R&D sites, including the one in Holly Springs.